Literature DB >> 9525579

Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice.

V J Cavanaugh1, L G Guidotti, F V Chisari.   

Abstract

We have previously demonstrated that hepatitis B virus (HBV) replication and gene expression are abolished in the livers of HBV transgenic mice by cytotoxic T lymphocytes (CTLs) and during lymphocytic choriomeningitis virus (LCMV) infection, stimuli that trigger the production of alpha/beta interferon, gamma interferon, and tumor necrosis factor alpha in the liver. We now report that hepatic HBV replication and gene expression are inhibited by the local induction of these cytokines during adenovirus- and murine cytomegalovirus (MCMV)-induced hepatitis. Further, we show that MCMV also blocks HBV replication and gene expression in the proximal convoluted tubules of the kidney by causing interstitial nephritis and inducing the same cytokines in the renal parenchyma. These results suggest that inflammatory cytokines probably contribute to viral clearance during acute viral hepatitis in humans, and they imply that induction of these cytokines in the liver and other infected tissues of chronically infected patients might have therapeutic value.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525579      PMCID: PMC109701          DOI: 10.1128/JVI.72.4.2630-2637.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

Authors:  Y Yang; F A Nunes; K Berencsi; E E Furth; E Gönczöl; J M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

2.  Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses.

Authors:  Y Yang; Q Li; H C Ertl; J M Wilson
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

3.  Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity.

Authors:  J A Symons; A Alcamí; G L Smith
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

4.  Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice.

Authors:  L G Guidotti; V Martinez; Y T Loh; C E Rogler; F V Chisari
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

5.  The myxoma virus TNF-receptor homologue (T2) inhibits tumor necrosis factor-alpha in a species-specific fashion.

Authors:  M Schreiber; G McFadden
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

6.  The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections.

Authors:  M T Heise; H W Virgin
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

7.  Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity.

Authors:  A Alcamí; G L Smith
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

8.  Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study.

Authors:  I S Sheen; Y F Liaw; D Y Lin; C M Chu
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

9.  MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

Authors:  Y Yang; H C Ertl; J M Wilson
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

10.  Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor.

Authors:  P Lucin; S Jonjić; M Messerle; B Polić; H Hengel; U H Koszinowski
Journal:  J Gen Virol       Date:  1994-01       Impact factor: 3.891

View more
  60 in total

Review 1.  Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B.

Authors:  F V Chisari
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.

Authors:  T Zhou; J T Guo; F A Nunes; K L Molnar-Kimber; J M Wilson; C E Aldrich; J Saputelli; S Litwin; L D Condreay; C Seeger; W S Mason
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: A single-center study.

Authors:  Francesco Marchesi; Fulvia Pimpinelli; Svitlana Gumenyuk; Daniela Renzi; Francesca Palombi; Francesco Pisani; Atelda Romano; Antonio Spadea; Elena Papa; Marco Canfora; Fabrizio Ensoli; Andrea Mengarelli
Journal:  World J Transplant       Date:  2015-09-24

Review 4.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

Review 5.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Rapid upregulation of interferon-regulated and chemokine mRNAs upon injection of 108 international units, but not lower doses, of adenoviral vectors into the brain.

Authors:  Jeffrey M Zirger; Carlos Barcia; Chunyan Liu; Mariana Puntel; Ngan Mitchell; Iain Campbell; Maria Castro; Pedro R Lowenstein
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

7.  Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site.

Authors:  T Heise; L G Guidotti; F V Chisari
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

8.  Clearance of chronic HCV infection during acute delta hepatitis.

Authors:  K Deterding; S V Pothakamuri; V Schlaphoff; J Hadem; F Metzler; M J Bahr; M P Manns; M Cornberg; H Wedemeyer
Journal:  Infection       Date:  2007-12-14       Impact factor: 3.553

9.  Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo.

Authors:  Melanie Fiedler; Florian Rödicker; Valentina Salucci; Mengji Lu; Luigi Aurisicchio; Uta Dahmen; Li Jun; Olaf Dirsch; Brigitte M Pützer; Fabio Palombo; Michael Roggendorf
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Association between polymorphism of tumor necrosis factor-alpha promoter and response to lamivudine treatment in patients with chronic hepatitis B.

Authors:  Yong Kwang Park; Jung Min Lee; Do Young Kim; Hye Young Chang; Ja Kyung Kim; Chun Kyon Lee; Jun Yong Park; Sang Hoon Ahn; Kwan Sik Lee; Kwang Hyub Han
Journal:  Dig Dis Sci       Date:  2009-10-15       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.